Abstract
AbstractThe two species that account for most cases ofAcinetobacter-associated bacteraemia in the UK areAcinetobacter lwoffii, often a commensal but also an emerging pathogen, andA. baumannii, a well-known antibiotic-resistant species. While these species both cause similar types of human infection and occupy the same niche,A. lwoffii(unlikeA. baumannii) has thus far remained susceptible to antibiotics. Comparatively little is known about the biology ofA. lwoffiiand this is the largest study on it conducted to date, providing valuable insights into its behaviour and potential threat to human health.This study aimed to explain the antibiotic susceptibility, virulence, and fundamental biological differences between these two species. The relative susceptibility ofA. lwoffii, was explained as it encoded fewer antibiotic resistance and efflux pump genes thanA. baumannii(9 and 30 respectively). While both species had markers of horizontal gene transfer,A. lwoffiiencoded more DNA defence systems and harboured a far more restricted range of plasmids. Furthermore,A. lwoffiidisplayed a reduced ability to select for antibiotic resistance mutations, form biofilm and infect bothin vivoandin vitromodels of infection.This study suggests that the emerging pathogenA. lwoffiihas remained susceptible to antibiotics because mechanisms exist to make it highly selective about the DNA it acquires, and we hypothesise that the fact that it only harbours a single RND system restricts the ability to select for resistance mutations. This provides valuable insights into how development of resistance can be constrained in Gram negative bacteria.ImportanceAcinetobacter lwoffiiis often a harmless commensal but is also an emerging pathogen and is the most common cause ofAcinetobacter-derived blood stream infections in England and Wales. In contrast to the well-studied, and often highly drug resistantA. baumannii,A. lwoffiihas remained susceptible to antibiotics. This study explains why this organism has not evolved resistance to antibiotics. These new insights are important to understand why and how some species develop antibiotic resistance, while others do not and could inform future novel treatment strategies.
Publisher
Cold Spring Harbor Laboratory
Reference50 articles.
1. Darby EM , Bavro VN , Dunn S , McNally A , Blair JM . 2023. RND pumps across the genus Acinetobacter: AdeIJK is the universal efflux pump. Microbial Genomics 9.
2. World Health Organisation. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed.
3. Acinetobacter baumannii: a universal threat to public health?
4. United Kingdom Health Security Agency. 2021. Laboratory surveillance of Acinetobacter spp. bacteraemia in England 2020.
5. Mathai E , Mathai M , Schramm M , Baravilala W . 2001. Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. The National medical journal of India 14.